An exploratory analysis within the acute neurological disorders group showed no differences in tau concentrations between ischaemic stroke and status epilepticus, whereas all CSF t-tau biomarkers were significantly higher after ischaemic stroke compared to Alzheimer’s disease (P < 0.01 for all biomarkers). The gene discussed is MAPT; the disease is ischemic stroke.